Linked Life Data

21522004

Source:http://linkedlifedata.com/resource/pubmed/id/21522004

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2011-6-29
pubmed:abstractText
We evaluated the long-term efficacy of raltegravir according to HIV-1 subtype (B and non-B) using data from three phase III studies in treatment-experienced (BENCHMRK-1 and 2) and treatment-naive (STARTMRK) HIV-infected patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1473-5571
pubmed:author
pubmed:issnType
Electronic
pubmed:day
17
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1365-9
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studies.
pubmed:affiliation
University of Bonn, Bonn-Venusberg, Germany.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III